No Image Available

Deep venous stents

Abre™ venous self-expanding stent system

The Abre™ venous self-expanding stent system is designed for the unique challenges of venous disease.

Ordering information
Contact a representative

Explore the Abre™ venous stent system.

Simplicity for you. 
Durability for them.

Watch the Abre™ stent mechanism of action.

Indications

The Abre™ stent system is intended for use in the iliofemoral veins for the treatment of symptomatic venous outflow obstruction.

Clinical evidence

Clinically meaningful impact on quality of life through 36 months — in even the most complex patients.

36-month primary patency†,1:

  • 81.6% overall
  • 97.1% NIVL
  • 76.5% aDVT
  • 70.4% PTS
View full evidence

Product details

Simplicity for you1,2

Hear it from the expert.

Durability for them1,2

Hear it from the expert.

Easy deployment to let you focus on your patient1,2

The Abre™ stent minimizes jumping and foreshortening, landing precisely where you need it.2

Rotating thumbwheel offers predictable placement and auditory feedback.2

The Abre™ delivery system is designed for simplicity and the rotating thumbwheel offers auditory feedback.
  1. Isolation sheath
  2. Hemostatic valve
  3. Introducer sheath
  4. Retractable sheath
  5. Inner shaft
The Abre™ delivery system is designed for simplicity and the triaxial shaft design increases stability during deployment.

Demonstrated endurance to give your patients freedom of movement1,2

The nitinol Abre™ stent maintains lumen integrity and flow in diverse patients and anatomies.1 It ensures radial strength and crush resistance, without compromising flexibility.2

Unique technology:

  • Open-cell design with three offset connection points
  • Struts customized to each size

Consistent behavior across a broad range of diameters and lengths.2

A young woman stretches her legs on a grassy hill.

Bench evidence shows long-term durability.2 Clinical evidence shows real-world dependability, even in challenging cases.1

  • 0% fracture rate in clinical trial with 44% of stents extending below inguinal ligament into the common femoral vein (CFV)‡,1
  • 0% migration rate in clinical trial1

Ordering information

Item number guide

The Abre venous stent comes in a broad range of sizes and diameters.
Stent diameter (mm) Stent length (mm)
40 60 80 100 120 150
10 AB9G10040090 AB9G10060090 AB9G10080090 AB9G10100090 AB9G10120090 AB9G10150090
12 — AB9G12060090 AB9G12080090 AB9G12100090 AB9G12120090 AB9G12150090
14 — AB9G14060090 AB9G14080090 AB9G14100090 AB9G14120090 AB9G14150090
16 — AB9G16060090 AB9G16080090 AB9G16100090 AB9G16120090 AB9G16150090
18 — AB9G18060090 AB9G18080090 AB9G18100090 AB9G18120090 AB9G18150090
20 — AB9G20060090 AB9G20080090 AB9G20100090 AB9G20120090 AB9G20150090

Related links

† Primary patency was defined as meeting all of the following: freedom from occlusion or restenosis ≥ 50% of the stented segment of the target lesion and freedom from clinically driven target lesion revascularization.

‡ Stent fracture and stent location was assessed by imaging core labs. Site reported data was used when core lab data was not available.

§ TLR was defined as any reintervention of the stented segment of the target lesion.

  1. Abre™ venous stent instructions for use.
  2. Test data on file at Medtronic. Report 10558227DOC_Rev A. Bench test results may not be indicative of clinical performance.

  1. Vogel J, Cheng C, Murphy E, Black S, Desai K. Fatigue test method to evaluate the 50 year durability of venous stents. Eur J Vasc Endovasc Surg. 2024;68(4):521–528. doi:10.1016/j.ejvs.2024.06.024.